Lakefront Biotherapeutics (LKFT) Return on Invested Capital (2020)

Lakefront Biotherapeutics (LKFT) reported Return on Invested Capital of 0.0% for Q1 2020.

Lakefront Biotherapeutics (LKFT) Return on Invested Capital (2020) Analysis & Trends

Lakefront Biotherapeutics (LKFT) has 1 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2020.

  • Return on Invested Capital for Q1 2020 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
  • Return on Invested Capital steadied at 0.0% in Q1 2020 per LKFT's latest filing.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q1 2020 and troughed at 0.0% in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.01%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -0.01%
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -0.01%
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 0.00%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Lakefront Biotherapeutics 9.64 Bn 9.64 Bn 1.97 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2020 0.00%